APA (7th ed.) Citation

Badau, L. M., Epure, P., Margan, M., Margan, R., Ciocoiu, A. D., Oprean, C. M., & Vlaicu, B. (2026). Body Mass Index and Outcomes in HR+/HER2− Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study. Cancers, 18(9), 1379. https://doi.org/10.3390/cancers18091379

Chicago Style (17th ed.) Citation

Badau, Larisa Maria, Paul Epure, Madalin-Marius Margan, Roxana Margan, Andrei Dorin Ciocoiu, Cristina Marinela Oprean, and Brigitha Vlaicu. "Body Mass Index and Outcomes in HR+/HER2− Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study." Cancers 18, no. 9 (2026): 1379. https://doi.org/10.3390/cancers18091379.

MLA (9th ed.) Citation

Badau, Larisa Maria, et al. "Body Mass Index and Outcomes in HR+/HER2− Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study." Cancers, vol. 18, no. 9, 2026, p. 1379, https://doi.org/10.3390/cancers18091379.